Coagulation Factor X Human

FDA Drug Profile — Coagadex

Coagulation Factor X Human is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Coagadex. Available dosage form: kit.

Drug details

Generic Name
Coagulation Factor X Human
Brand Names
Coagadex
Application Number
BLA125506
Sponsor
Bio Products Laboratory Ltd
NDC Codes
2
Dosage Forms
KIT

Indications and Usage

1 INDICATIONS AND USAGE COAGADEX, Coagulation Factor X (Human), is a plasma-derived human blood coagulation Factor indicated in adults and children with hereditary Factor X deficiency for: Routine prophylaxis to reduce the frequency of bleeding episodes On-demand treatment and control of bleeding episodes Perioperative management of bleeding in patients with mild, moderate, and severe hereditary Factor X deficiency COAGADEX, Coagulation Factor X (Human), is a plasma-derived human blood coagulation factor indicated in adults and children with hereditary Factor X deficiency for: Routine prophylaxis to reduce the frequency of bleeding episodes ( 1 ) On-demand treatment and control of bleeding episodes ( 1 ) Perioperative management of bleeding in patients with mild, moderate and severe hereditary Factor X deficiency ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.